| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 01/05/2012 | WO2011112558A3 Solid compositions |
| 01/05/2012 | WO2011109365A3 Concentrated protein formulations and uses thereof |
| 01/05/2012 | WO2011107970A3 Rifaximin powder, process for preparing the same and controlled release compositions containing said rifaximin useful for obtaining a long-lasting effect. |
| 01/05/2012 | WO2011099804A3 Novel antifungal triazole derivatives |
| 01/05/2012 | WO2011055139A3 Antimicrobial and anti-acne formulations |
| 01/05/2012 | WO2011044538A9 Antibacterial aminoglycoside analogs |
| 01/05/2012 | US20120005790 Analogs of temporin-sha and uses thereof |
| 01/05/2012 | US20120005768 Circovirus Sequences Associated With Piglet Weight Loss Disease (PWD) |
| 01/05/2012 | US20120004593 Antiseptic based on bispyridinium alkanes |
| 01/05/2012 | US20120004314 Antimicrobial composition |
| 01/05/2012 | US20120004279 Compositions and methods for modulating activity of capped small rnas |
| 01/05/2012 | US20120004275 Sceletium extract and uses thereof |
| 01/05/2012 | US20120004272 Biocidal composition of 2,6-dimethyl-m-dioxane-4-ol acetate and methods of use |
| 01/05/2012 | US20120004244 Bis Aromatic Compounds for Use as LTC4 Synthase Inhibitors |
| 01/05/2012 | US20120004228 Bis Aromatic Compounds for Use as LTC4 Synthase Inhibitors |
| 01/05/2012 | US20120004224 Triheterocyclic Compounds and Compositions Thereof |
| 01/05/2012 | US20120004221 Antibacterial Compositions |
| 01/05/2012 | US20120004207 Therapeutic uses of derivatives of piperidinyl-and piperidinyl-alkyl carbamates |
| 01/05/2012 | US20120004196 Anti-Viral Compounds |
| 01/05/2012 | US20120004190 Heterobifunctional pan-selectin inhibitors |
| 01/05/2012 | US20120004174 Gh secretagogues and uses thereof |
| 01/05/2012 | US20120004161 Homogenous preparations of il-28 and il-29 |
| 01/05/2012 | US20120004160 Methods for identifying and compounds useful for the diagnosis and treatment of diseases involving inflammation |
| 01/05/2012 | US20120004159 Polypeptides having antimicrobial activity and polynucleotides encoding same |
| 01/05/2012 | US20120004158 Quaternised Ammonium Cyclodextrin Compounds |
| 01/05/2012 | US20120003340 Compositions and methods for detoxification and cancer prevention |
| 01/05/2012 | US20120003320 Particles which are surface coated with hyaluronan or one of the derivatives thereof and the use of same as biological vectors for active substances |
| 01/05/2012 | US20120003316 Transmucosal delivery system |
| 01/05/2012 | US20120003300 Composition Comprising Vascular Endothelial Growth Factor (VEGF) for the Treatment of Hair Loss |
| 01/05/2012 | US20120003295 Lipid a and other carbohydrate ligand analogs |
| 01/05/2012 | US20120003293 Nitric oxide-releasing dressings |
| 01/05/2012 | US20120003285 Method for manufacturing capsule series, and related capsule series |
| 01/05/2012 | US20120003277 Nanoemulsion vaccines |
| 01/05/2012 | US20120003269 Compositions Produced Using Enteric Pathogens and Methods of Use |
| 01/05/2012 | US20120003266 Virus like particle compositions and methods of use |
| 01/05/2012 | US20120003265 Immunogenic compositions for inducing an immune response to hiv |
| 01/05/2012 | US20120003264 CDNA Corresponding to the Antigenome of Nonsegmented Negative Stranded RNA Viruses and Process for the Production of Such Viruses |
| 01/05/2012 | US20120003263 Recombinant raccoon pox virus vaccine against highly pathogenic avian influenza |
| 01/05/2012 | US20120003259 Molecule |
| 01/05/2012 | US20120003258 Mutant forms of streptolysin o |
| 01/05/2012 | US20120003257 Recombinant avian infectious coryza vaccine and process for preparing same |
| 01/05/2012 | US20120003256 Tuberculosis antigens, immunogenic compositions, diagnostics and methods related to the same |
| 01/05/2012 | US20120003255 Flavivirus host-range mutations and uses thereof |
| 01/05/2012 | US20120003241 Vaccine against botulism |
| 01/05/2012 | US20120003240 Enterovirus Vaccines for Preventing or Treating Type 1 Diabetes (III) |
| 01/05/2012 | US20120003239 Enterovirus Vaccines for Preventing and Treating Type 1 Diabetes (II) |
| 01/05/2012 | US20120003223 Recombinant fusion protein and polynucleotide construct for immunotoxin production |
| 01/05/2012 | US20120003215 Pyrazolo[1,5-a]pyrimidines for antiviral treatment |
| 01/05/2012 | US20120003205 Pharmaceutical composition containing arazyme for the prevention of liver dysfunction |
| 01/05/2012 | US20120003203 Compositions and Methods for Treating S. Pneumoniae Infection |
| 01/05/2012 | US20120003188 Compositions and Methods of Using Living and Non-Living Bioactive Devices with Components Derived from Self-Renewing Colony Forming Cells Cultured and Expanded In Vitro |
| 01/05/2012 | US20120003175 Therapeutic uses of mastic gum fractions |
| 01/05/2012 | US20120003174 Otic compositions for the treatment of infections of the internal and external ear in mammals |
| 01/05/2012 | CA2804319A1 Benzofuran derivatives for the treatment of hepatits c |
| 01/05/2012 | CA2804201A1 Stable antiseptic compositions and methods |
| 01/05/2012 | CA2804149A1 Nanoemulsion vaccines |
| 01/05/2012 | CA2803989A1 Env trimer immunogens |
| 01/05/2012 | CA2803619A1 Heterocycle compounds and their uses |
| 01/05/2012 | CA2803444A1 Use of leukotriene b4 in combination with a toll-like receptor ligand, a rig-l-like receptor ligand or a nod-like receptor ligand to enhance the innate immune response |
| 01/05/2012 | CA2803298A1 Compositions and methods related to protein a (spa) variants |
| 01/05/2012 | CA2802492A1 2-quinolinyl-acetic acid derivatives as hiv antiviral compounds |
| 01/05/2012 | CA2802308A1 Napht-2-ylacetic acid derivatives to treat aids |
| 01/05/2012 | CA2800836A1 Riminophenazines with 2-(heteroaryl)amino substituents and their anti-microbial activity |
| 01/04/2012 | EP2402365A1 Crystal structure of amino terminal portion of influenza virus polymerase pa subunit and use thereof |
| 01/04/2012 | EP2402359A1 Recombinant protective protein from streptococcus pneumoniae |
| 01/04/2012 | EP2402358A2 2',3'-Didehydro-3'-deoxy-4'-ethynylothymidine derivatives for treatment infections caused by human immunodeficiency virus (HIV) multidrug resistant strains, method of their synthesis and pharmaceutically acceptable forms of drugs |
| 01/04/2012 | EP2402357A1 Analogs of 2',3'-dideoxy-3'-fluorothymidine 5'-monophosphate (FLTMP) for treatment human immunodeficiency virus (HIV), their application and pharmaceutically acceptable form of drug |
| 01/04/2012 | EP2402356A2 Modified 2',3'-dideoxynucleosides for treatment infections caused by human immunodeficiency virus (HIV) multidrug resistant strains, method of their synthesis and the pharmaceutical agent containing these nucleosides |
| 01/04/2012 | EP2402355A1 Crystalline anhydrous forms II and III of Tulathromycin |
| 01/04/2012 | EP2402331A1 Inhibitors of serine proteases |
| 01/04/2012 | EP2402031A1 Immunologic adjuvant composition and use thereof |
| 01/04/2012 | EP2402029A1 Enterovirus vaccines for preventing or treating type 1 diabetes (III) |
| 01/04/2012 | EP2402028A1 Enterovirus vaccines for preventing and treating type 1 diabetes (II) |
| 01/04/2012 | EP2402026A2 Method for isolating hepatitis C virus peptides |
| 01/04/2012 | EP2402015A2 Method of producing sophorolipids by fermentation of candida bombicola |
| 01/04/2012 | EP2402014A2 Application of sophorolipids synthesized by fementation of candida bombicola |
| 01/04/2012 | EP2402011A1 Intermediates in the synthesis of S-triazolyl alpha-mercaptoacetanildes as inhibitors of HIV reverse transcriptase |
| 01/04/2012 | EP2402009A1 Inhibitors of serine protease, particularly hepatitis c virus NS3-NS4A protease, incorporating a fused ring system |
| 01/04/2012 | EP2401282A1 Method for the production of amorphous rifaximin |
| 01/04/2012 | EP2401280A1 Cyclopropyl fused indolobenzazepine hcv ns5b inhibitors |
| 01/04/2012 | EP2401272A2 Amorphous salt of a macrocyclic inhibitor of hcv |
| 01/04/2012 | EP2401264A2 Peptoid oligomers, pharmaceutical compositions and methods of using the same |
| 01/04/2012 | EP2400966A1 Combination of a nucleoside polymerase inhibitor with a macrocyclic protease inhibitor and use thereof in the treatment of hepatitis c, liver fibrosis and impaired liver function |
| 01/04/2012 | EP2400846A1 Hepatitis c virus inhibitors |
| 01/04/2012 | EP2400845A1 Thienopyridine derivatives for the treatment and prevention of dengue virus infections |
| 01/04/2012 | EP2400843A1 Iminosugars and methods of treating arenaviral infections |
| 01/04/2012 | EP2047857B1 Agent for injection purposes comprising antibiotic, and solution for injection comprising the agent |
| 01/04/2012 | EP1986620B1 Dextromethorphan for the treatment of acne |
| 01/04/2012 | EP1898948B1 Polyinosinic acid-polycytidylic acid-based adjuvant |
| 01/04/2012 | EP1814596B1 Antisense antiviral compounds and methods for treating filovirus infection |
| 01/04/2012 | EP1671635B1 Noncrystalline antibacterial composition containing cefditoren pivoxil |
| 01/04/2012 | EP1494649B1 Nanoparticulate megestrol formulations |
| 01/04/2012 | EP1441720B1 Inhibitors of serine protease, particularly hepatitis c virus ns3-ns4a protease, incorporating a fused ring system |
| 01/04/2012 | EP0914142B9 Peptides with increased binding affinity for at least three hla-a3-like molecules |
| 01/04/2012 | CN102307898A Method for producing comprehensive anti-surface antibody wherein the antigen used is a microorganism fixed by a protein crosslinking and fixation reagent |
| 01/04/2012 | CN102307896A Fibronectin type III domain based scaffold compositions, methods and uses |
| 01/04/2012 | CN102307890A Hepatitis c virus inhibitors |
| 01/04/2012 | CN102307871A Isoindolinone and related analogs as sirtuin modulators |
| 01/04/2012 | CN102307842A Plant extracts from acronychia species and their use |
| 01/04/2012 | CN102307590A Influenza vaccines with reduced amounts of squalene |